MedPath

The comparison between Beclomethason Dipropionate and Fluticasone Propionate in 6-16 year old patients with moderate asthma

Phase 2
Conditions
Effects of inhaled corticosteroids (ICS) in moderate asthma.
Asthma
Registration Number
IRCT138812042976N2
Lead Sponsor
Zanjan University Of Medical Science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Other
Sex
All
Target Recruitment
50
Inclusion Criteria

Patients with symptoms of cough and wheezing at night and after exercise and FEV1 between 60-80% were included in the study. Patients with other known causes of wheezing such as cystic fibrosis and heart disorders were excluded from entry into study. None of patients had been receiving inhaled corticosteroids prior the study.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement of daily symptoms. Timepoint: weekly. Method of measurement: questionare.;Improvement of night symptoms. Timepoint: monthly. Method of measurement: questionare.;Reduction of rescue medication. Timepoint: monthly. Method of measurement: questionare.
Secondary Outcome Measures
NameTimeMethod
Improvement of PFT. Timepoint: monthly. Method of measurement: spirometeric measurement.
© Copyright 2025. All Rights Reserved by MedPath